Objective: To evaluate Brachychiton acerifolius leaf extracts as antidiabetic potential agent and to identify the main active constituents using bioactivity guided fractionation. Methods: In vitro antioxidant activity was evaluated for B. acerifolius different extracts using DPPH assay and vitamin C as control. Antidiabetic activity was then determined using STZ-induced rats treated daily with ethyl acetate and 70% ethanol leaf extracts for 4 weeks at a dose of 200 g/kg body weight against gliclazide reference drug. Blood glucose, a-amylase, lipid profile, liver function enzymes and oxidative stress markers were assessed along with histopathological study for liver and pancreatic tissues. Isolation and structural elucidation of active compounds were made using Diaion and Sephadex followed by spectral analyses. Results: The results indicated that ethyl acetate and ethanol leaf extracts exhibited the strongest antioxidant activity compared to that of vitamin C (IC 50 0.05, 0.03 and 12 mg/ mL, respectively). Both extracts showed potent anti-hyperglycemic activity evidenced by a significant decrease in serum glucose levels by 82.5% and 80.9% and a-amylase by 45.2% and 53.6%, as compared with gliclazide 68% and 59.4%, respectively. Fractionation of ethanol extract resulted in the isolation of 9 flavonoids including apigenin-7-O-arhamnosyl ( 
Introduction
Diabetes mellitus is a heterogeneous group of disorders in protein, fat and carbohydrate metabolism, portrayed by chronic hyperglycemia [1] . As indicated by the International Diabetes Federation (2015), 415 million adult people are diabetic; by 2040 this will ascend to 642 million. Diabetes brought on 4.9 million deaths in 2014 and this is cited in the IDF report as being the fourth or fifth driving reason of death in most high income countries and an epidemic disease in economically developing ones. The expanded morbidity associated with diabetes is secondary to a number of pathological conditions, embracing dyslipidemia, neuropathy, cerebrovascular disorders, renal insufficiency and coronary heart disease [2] . Free radicals height and hepatic failure were additionally associated with diabetes [3] .
In response to the increasing demands for discovering new antidiabetic drugs of natural origin, this study assessed the antidiabetic activity of Brachychiton acerifolius (B. acerifolius) (A. Cunn. ex G. Don) Macarthur (Malvaceae) defatted leaf extract using bioactivity guided fractionation. B. acerifolius, an Australian tree cultivated worldwide, belongs to a genus and family of known antidiabetic herbal drugs among several other activities [4] [5] [6] [7] [8] . The genus is reported for a myriad of chemical compounds, including flavonoids, alkaloids, sterols, terpenes and coumarins [9, 10] . However, no previous biological activities have been reported for B. acerifolius except for the strong antioxidant activity of its leaf crude extract [11] . This study included successive extraction of B. acerifolius leaf powder with solvents of increasing polarity, in vitro antioxidant activity assay for the successive extracts as a rapid screening tool for extract activity [12] , most potent of which were further assessed for their antidiabetic activity. Finally, isolation attempt was made to isolate and identify the major chemical forms present in the leaf alcohol extract and are likely to mediate for its antidiabetic effect.
Materials and methods

Plant material and animals
B. acerifolius leaf was collected during April-May 2012 from Agricultural Museum, Giza Governorate, Egypt. The plant material was kindly authenticated by Therese Labib, Agricultural engineer, specialist of plant scientific classification at the Ministry of Agriculture and ex-director of the Orman botanical garden, Giza, Egypt. Plant samples were deposited at Faculty of Pharmacy-Cairo University (voucher No.: 16-6-2014 ). In the current study, male Wistar albino rats (150:180 g) were provided from the Animal House, National Research Centre, Egypt. All experimental procedures involving animals were conducted in accordance with the moral rules of the Medical Ethical Committee of National Research Centre in Egypt (Approval No: 12035).
Chemicals, reagents and materials
Petroleum ether 60-80 C, ethanol and acetic acid were purchased from Adwic (Egypt). Chloroform, ethyl acetate, methanol, formaldehyde, streptozotocin, quercetin, kaempferol, NaOMe, AlCl 3 , HCl, NaOAc and H 3 BO 3 were obtained from Sigma Aldrich (USA). Shift reagents and chemicals for UV spectroscopic analysis of flavonoids were prepared as mentioned in detail elsewhere [13] . Sephadex LH-20 (25-100 mm) and 1,1-diphenyl-2-picryl-hydrazil (DPPH) were purchased from Sigma-Aldrich Chemie GmbH (Germany). Diaion HP-20 was obtained from SUPELCO (USA), vitamin C from Cid Co., (Egypt), gliclazide (diamicron ® ) from Servier (France) and nbutanol from alpha chemicals (Egypt). Kits for the assessment of: blood glucose [14] , a-amylase [15] , lipid profile [16] , liver oxidative stress markers: GSH, MDA and SOD and serum liver function enzymes [17] were provided from Biodiagnostics (Spectrum, Egypt).
Extraction procedure for B. acerifolius leaves
One kilogram of B. acerifolius air dried leaves powder was macerated on cold with petroleum ether 60-80 C for defatting.
The marc was then successively macerated on cold with chloroform, ethyl acetate and 70% ethanol to yield 27 g, 7.5 g and 100 g, respectively.
In vitro antioxidant activity
Serial dilutions of chloroform, ethyl acetate and 70% ethanol leaf extracts spanning from 10 till 100 mg/mL were assessed for their antioxidant effect by the method of Awad et al. [16] , where DPPH solution prepared at a concentration of 50 mmol/L react with plant antioxidants and the decrease in absorbance (A) of DPPH − (at 517 nm) was calculated in relation to absorbance of control (blank) as follows: Percentage inhibition = (A control -A sample )/ A control × 100. Vitamin C was used as a standard. Thirty male Wistar strain albino rats (150-180 g) were divided to estimate the acute toxicity of ethyl acetate and 70% ethanol leaf extracts at different concentrations (100, 200 and 500 g/kg body weight) with 5 rats/group. Animals were observed for 15 consecutive days and accordingly, safety dose was monitored and recorded.
In vivo antidiabetic activity determination
Thirty-five male Wistar strain albino rats (150-180 g) were divided into 7 groups (5 rats/group) in which Group 1: normal healthy control rats, Groups 2-3: normal healthy rats, orally administrated daily with ethyl acetate and 70% ethanol leaf extracts (200 g/kg, as determined by LD 50 experiment) for 4 weeks to evaluate their adverse effects over liver and pancreas, Group 4: injected with a single dose of streptozotocin i.p. (STZ, 35 mg/kg) to induce diabetes [18] , Groups 5-6: i.p. injected with STZ and orally treated, after five days of STZ injection, with ethyl acetate and 70% ethanol leaf extracts (200 g/kg) daily for 4 weeks, Group 7: i.p. injected with STZ and treated with gliclazide (30 mg/kg body weight) after five days of STZ injection, for 4 weeks and serve as a reference group. Diabetic rats with a glucose level >300 mg/dL were used for this experiment. Blood samples were collected in clean dry test tubes, left for 10 min to clot and then centrifuged at 3000 r/min for serum separation. The separated serum was stored at −80 C for determination of glucose, a-amylase, lipid profile and liver function enzymes level. Liver tissue was homogenized in cold 0.9 mol/L NaCl (1:10 w/v), centrifuged at 3000 r/min for 10 min, the supernatant was separated and stored at −80 C for the assay of oxidative stress markers and total protein content.
Histopathological study
Representative slices of liver and pancreatic tissues were fixed in 10% formalin. Paraffin-embedded sections (4 mm thick) were stained with haematoxylin and eosin (H&E) [19] . Slides were seen under a light microscope with magnification power 200×.
Statistics
All data were expressed as mean ± SD of rats' number in each group. Statistical analysis was carried out by One-way (14 g ) was selected for further fractionation on diaion using the same eluting system. Eventually, upon spotting on PC Whatmann No. 1 in solvent systems BAW (S1) and 15% acetic acid (S2), the 25% methanol fraction (1.5 g) was selected for separation and purification of compounds on Sephadex column (10:1) with gradient eluting system: 100% H 2 O, 5% MeOH, 10% MeOH, 20% MeOH and 50% MeOH. Similar sub-fractions were pooled together and further purified on Sephadex (10:1) using 50% MeOH to yield 5 flavonoid glycosides and 4 aglycones.
Spectral analyses
UV spectroscopy used for detecting l max in MeOH and shift reagents (UV-VIS double beam UVD-3500 spectrophotometer, Labomed, Inc.). Mass spectral data were obtained by UPLC-PDA-high resolution (HR) qTOF-ESI/MS (Bruker Daltonics) with the mechanism and conditions explained in Farag et al. [14] , and UPLC/ITMS (Thermo Electron, San Jose, USA) equipped with an ESI source (electrospray voltage 4.0 kV, sheath gas: nitrogen; capillary temperature: 275 C) in negative ionization mode with ion-trap mass detector for performing tandem MS/ MS and confirming MS fragment entities. Acquired NMR data include 1 H, 13 C, Correlation spectroscopy (COSY), Heteronuclear Single Quantum Coherence (HSQC) and Heteronuclear multiple-bond correlation spectroscopy (HMBC). All 1 H and 13 C spectra were recorded on an Agilent (Varian) VNMRS 600 NMR spectrometer operating at a proton and carbon NMR frequencies of 599.83 and 150.83 (MHz), respectively. 2D NMR spectra were recorded using standard CHEMPACK 4.1 pulse sequences (DQCOSY, HSQCAD, HMBCAD) implemented in Varian VNMRJ 2.2C spectrometer software. The conditions for 1D and 2D NMR analyses were adjusted as mentioned in Farag et al. [20] .
Results
In vitro antioxidant activity determination for successive leaf extract using DPPH assay
Results of scavenging DPPH free radicals are expressed as IC 50 values (mg/mL): 0.03, 0.05, 0.3 and 12; for 70% ethanol, ethyl acetate, chloroform successive leaf extracts and vitamin C, respectively.
Acute toxicity determination (LD 50 )
Ethyl acetate and 70% ethanol leaf extracts were orally administered at three concentrations (100, 200 and 500 g/kg body weight). Absence of death was revealed for both extracts at different dose levels after 15 days of treatment, accordingly the median dose (200 g/kg body weight) was selected for further in vivo experiments.
In vivo antidiabetic activity determination
Leaf extracts [i.e. ethyl acetate (EA) and 70% ethanol (E)] were evaluated as antidiabetic agents in vivo by monitoring changes in rat serum glucose, a-amylase, lipid profile, liver function enzymes and oxidative stress parameter levels to provide a complete overview on the biological impact of B. acerifolius extracts in healthy and diabetic rats. Change and improvement percentages for each parameter are presented along with the histopathological examination of liver and pancreatic tissues (Tables 1-3 and Figures 1-2 ).
Chemical investigation of E extract
Both B. acerifolius leaf extracts (EA and E) were found active against diabetes, as evidenced by a significant decrease in glucose and a-amylase levels in diabetic rats. Nevertheless, E showed an overall more favourable biochemical and histopathological effects in both healthy and diabetic rats and was thus subjected to further isolation attempts. UPLC-MS profiling of B. acerifolius crude leaf ethanol extract revealed the enrichment of flavone type glycosides suggesting that these forms amount for secondary metabolite composition in B. acerifolius leaf. To further clarify B. acerifolius flavonoids repertoire, additional purification and optimised chromatographic conditions were attempted. Moreover, further NMR analyses were made for the isolates, that is, the absolute stereochemistry and attachment position of sugars to flavonoid aglycones, not easily determined using UPLC-MS analysis. Fractionation and isolation attempts for most active 70% ethanol leaf extract led to the isolation of 9 flavonoids. Values are expressed as mean ± SD of five rats in each group. Statistical analysis is carried out by One-way ANOVA accompanied by Costat computer program using least significant difference (LSD) at P < 0.05. Unshared superscript letters indicate values of significant difference between groups. 
Spectral data of isolated compounds
Compound 1; apigenin-7-O-a-rhamnosyl (1/2) b-D-glucu-
Discussion
In vitro antioxidant activity of successive leaf extracts
The correlation between antioxidants and treatment of diabetes (type I & II) is well established in terms of ameliorating the diabetic status [21, 22] . Antioxidant assay of successive B. acerifolius leaf extracts showed promising antioxidant effects, albeit relatively less able to scavenge DPPH if compared to that of crude extract (IC 50 0.015 mg/mL) [11] , suggesting for a synergistic effect among B. acerifolius leaf constituents. Considering that both (E) and (EA) leaf extracts showed much lower IC 50 (0.03 and 0.05 mg/mL, respectively) than that of chloroform (0.3 mg/mL), both extracts were selected for further in vivo biological examination.
In vivo antidiabetic activity determination
Healthy rats treated with (EA) and (E) leaf extracts showed insignificant changes (P < 0.019) in glucose levels (−7.3% and −2.3%, respectively) compared to control group and thus exhibiting no hypoglycemic activity on normal blood glucose levels ( Figure 1A) . With regard to lipid profile, LDL-C was significantly reduced upon (EA) administration by 77.4% and (E) by 32.2%. Whereas, HDL-C showed a significant decrease in both extracts by 28.4% and 24.4%, respectively (Table 1) . Generally, the effect of extracts on healthy rats' lipid profile after 4 weeks was generally favourable except for HDL ( Figure 1B) . Kent et al. [23] reported reduction in HDL with a concurrent improvement in other cardiovascular risk indicators in healthy human subjects who follow plant-based diets. Such observation uncertain relying on HDL levels solely and suggests that non-HDL cholesterol levels ought to be measured for predicting the risk of cardiovascular diseases [24] . Concerning liver function enzymes, insignificant changes in AST, ALT and ALP enzymes activity were recorded ( Figure 1C ) compared to control group, revealing the extracts' safety on liver functions. Similarly, oxidative stress markers, malondialdehyde (MDA) and glutathione (GSH), showed insignificant changes (Table 1 ). In contrast, superoxide dismutase (SOD) recorded a significant decrease in healthy rats treated with (EA) and (E) by 67.7% and 72.6%, respectively ( Figure 1D ) suggesting for a decrease in free radical formation as SOD transcription is known to increase following an increase in free radicals to dismutate superoxide radicals into water and oxygen [25] .
On the other hand, upon i.p. STZ injection, the diabetic rats group recorded significant increase (P < 0.0001) in glucose and a-amylase levels by 432.1% and 327.6%, respectively, compared with healthy rats. After 4 weeks of treatment, significant decrease (P < 0.0001) in glucose was recorded by 82.5%
(EA) and 80.9% (E) compared to the diabetic group, a-amylase level was also decreased by 45.2% and 53.6%, respectively (Table 2, Figure 1A) . Similar results were observed in the reference drug (gliclazide) on glucose levels (reduced by 68%) and a-amylase (reduced by 59.4%). Consequently, both leaf extracts were considered to have remarkable anti-hyperglycemic activity with a comparable improvement % in glucose (EA:
439.2%, E: 430.8%) and a-amylase levels (EA: 193.3%, E: 229.4%) post treatment ( Table 3) .
The lipid profile ( Figure 1B ), showed significant reduction in TC, LDL, TG and total lipids upon treatment with both extracts to variable extents. Contradictory, HDL showed significant increase post treatment with (E) and gliclazide by 25.6% and 42.3%, respectively (Table 2) .
Liver function enzymes showed the highest improvement % in ALP (E: 71.2%) whereas other enzymes were not significantly altered in both extracts ( Table 3 ). The oxidative stress markers MDA and SOD that recorded a notable increase in diabetic rats by 329.7% and 58.4%, respectively, were significantly decreased upon treatment with (EA) by 59.3% and 38.1%, and (E) by 72.7% and 37.3%, respectively (Table 2 ). In contrast, GSH was significantly increased upon treatment with (EA) and (E) by 64.5%, 61.9%, respectively, compared to the diabetic group ( Figure 1D ).
Histopathological examination of liver tissue showed no signs of hepatotoxicity or damage in healthy rats treated with both extracts compared to the control group. Additionally, pancreatic tissue showed a remarkable improvement compared to the diabetic group as revealed by the size and arrangement of pancreatic islets (Figure 2 ).
From the above results, the effect of (EA) and (E) leaf extracts proved to be promising anti-hyperglycemic agents compared to the reference drug gliclazide, and no signs of obvious acute or chronic toxicities.
Chemical investigation of B. acerifolius 70% ethanol leaf extract
UV spectral data of the 9 isolated flavonoids revealed that compounds 1, 3-5, 8 and 9 were flavones from their band I l MeOH (<350 nm), whereas 2,6 and 7 were flavonols (band I l MeOH > 350 nm). UV data and co-chromatography with Authentics identified compounds 6 and 7 as quercetin and kaempferol, respectively. High resolution (-) ESI/MS enabled the detection of the molecular ion and the main fragments due to sugar losses in flavonoid glycosides (1) (2) (3) (4) (5) 26, 27] . While compound 2 was assigned as a diglycoside containing glucose and rhamnose moieties attached to a quercetin aglycone (m/z 301) [28] . Compounds 1, 4, 5 and 9 exhibited the same aglycone mass at m/z 269, C 15 H 9 O 5 − whereas compounds 3 [29] and 8 [30] (Table 4) . Glucuronic acid anomeric proton was observed at d5.25 ppm as a doublet peak (J = 7.4 Hz) indicating b-sugar configuration. With regard to the rhamnose moiety; a singlet anomeric proton was observed at an unusual downfield chemical shift (d5.31 ppm) and a doublet peak for C-6 methyl protons at d1.29 ppm (J = 6.1 Hz). Such NMR signal features of rhamnose protons suggest for 1/2 diglycoside sugar linkage with glucuronic acid further confirmed by 2D-NMR spectra. In detail, long range HMBC detected a cross peak between the anomeric proton of rhamnose H-1 000 at d5.3 ppm and a carbon peak at d79 ppm (glucuronic acid, C-2 00 ).
HSQC exhibited a correlation between C-2 00 and a proton at (Table 4) thus proving the 1/2 sugar linkage [26, 27] . To our knowledge, this is the first report for the presence ofapigenin-7-O-a-rhamnosyl (1/2)-b-glucuronide not only in B. acerifolius but rather in the whole genus. The 1 H NMR spectra of compounds 4 and 5 showed the same NMR peaks pattern for apigenin aglycone with sugar anomeric proton at d5.1/5.2 ppm as a complex multiplet signal due to the free rotation of the sugar moiety with respect to the aglycone [30] , albeit could be easily distinguished from their MS data. addition to H-3 singlet peak at d6.60 ppm. The anomeric proton of glucuronic acid was observed at d5.1 ppm (d, J = 7 Hz) with another distinct doublet peak for H-5 00 at d3.8 ppm (J = 9 Hz) [29] (Table 4) . To our knowledge, all identified flavonoids in this study are reported for the first time in B. acerifolius leaves except for compounds 2,6,7 and 8 [31] . It is noteworthy that the majority of the identified compounds in this investigation was consistent with the results derived via the UPLC/PDA/q-TOF/ESI-MS profiling analysis of B. acerifolius crude leaf extract, thus posing UPLC-MS as a robust technique for flavonoids profiling [11] . Most of the identified compounds are aglycones and glycosides of apigenin and luteolin, which are well known to reduce glucose absorption remarkably by competitive inhibition of sodium-dependent glucose transporter-1. Additionally, flavones can control blood glucose level via an inhibitory effect on a-glucosidase activity [32] . Furthermore, Mukherjee et al. [33] recommended apigenin and luteolin as leading drugs for treatment of diabetes mellitus.
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